Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Indivior
Company Monitoring Page for Indivior
latest headlines for company on cafepharma
U.S. court allows generic version of Indivior opioid abuse drug
Reuters
Wed, 11/21/18 - 09:49 am
Tags:
Dr Reddy's
,
Indivior
,
Suboxone Film
Teva holding off launch of opioid addiction drug
Pharmaforum
Wed, 09/12/18 - 11:27 am
Tags:
Teva Pharmaceutical
,
opioids
,
opioid addiction
,
generics
,
Dr Reddy's
,
Suboxone
,
Indivior
As it fights looming competition on Suboxone, Indivior gets FDA OK on new schizophrenia drug
Endpoints
Mon, 07/30/18 - 11:24 am
Tags:
Indivior
,
FDA
,
Perseris
,
schizophrenia
,
Suboxone
Indivior's shares soar 33 percent after U.S. court blocks sale of rival generic
Reuters
Mon, 07/16/18 - 10:26 pm
Tags:
Indivior
,
opioid addiction
,
generics
,
Suboxone Film
,
Dr Reddy's
Indivior shares dive after Dr Reddy's gets FDA approval for generic
Reuters
Fri, 06/15/18 - 09:49 pm
Tags:
Indivior
,
FDA
,
generics
,
Suboxone Film
,
opioids
,
opioid addiction
Thu, 04/5/18 - 09:12 am
Tags:
Suboxone Film
,
opioid addiction
,
Indivior
In a blow to its biggest revenue driver, Indivior loses patent battle with generics maker Alvogen
Endpoints
Fri, 03/23/18 - 09:52 am
Tags:
Indivior
,
patents
,
Suboxone
,
Alvogen
,
generics
12 blockbusters: The surging list of $1B-plus drugs rolling out on the market this year might surprise you
Endpoints
Thu, 03/22/18 - 09:21 am
Tags:
drug launches
,
Hemlibra
,
Roche
,
Biktarvy
,
Gilead Sciences
,
Ozempic
,
Novo Nordisk
,
Erleada
,
JNJ
,
Shingrix
,
GSK
,
Patisiran
,
Alnylam
,
Sanofi
,
Epidiolex
,
GW Pharma
,
Aimovig
,
Amgen
,
Novartis
,
lanadelumab
,
Shire
,
Elagolix
,
AbbVie
,
Steglatro
,
Pfizer
,
Merck
,
Sublocade
,
Indivior
FDA panel votes yes on Indivior’s opioid addiction drug
Endpoints
Wed, 11/1/17 - 09:51 am
Tags:
FDA
,
advisory panels
,
Indivior
,
opioid addiction
,
RBP-6000
,
buprenorphine
Reckitt Benckiser spinout climbs after PhIII schizophrenia trial hits endpoints
Fierce Biotech
Wed, 05/6/15 - 07:13 pm
Tags:
Reckitt Benckiser
,
schizophrenia
,
RBP-7000
,
Indivior
Indivior CEO looks beyond 2015 after troubled Reckitt pharma unit's spinoff
Fierce Pharma
Fri, 01/2/15 - 07:41 pm
Tags:
Reckitt Benckiser
,
Indivior
Pages
« first
‹ previous
1
2
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.